How to Buy Biolife Solutions Stock
Biolife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally.
Biolife Solutions stock last closed at $17.54, down 1.79% from the previous day, and has decreased 3.09% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.1 percentage points. Biolife Solutions stock is currently +96.64% from its 52-week low of $8.92, and -28.41% from its 52-week high of $24.50.
At the moment, there are 45.3M BLFS shares outstanding. The market value of BLFS is $794.56M. In the last 24 hours, 443,371 BLFS shares were traded.
How to Buy Biolife Solutions Stock
Not sure how to invest in Biolife Solutions stock? Here's how.
- Figure out where to buy Biolife Solutions stock: You need to pick an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you figure out where to buy Biolife Solutions stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your payment method and add your information.
- Research Biolife Solutions stock: The Biolife Solutions ticker symbol is BLFS. Is Biolife Solutions stock a good investment? Should you buy shares of BLFS? How do BLFS's underlying business fundamentals look? Do top analysts think Biolife Solutions is a good buy? Why has BLFS's stock price moved recently? (Hint: Our stock research tools can help you understand if BLFS is a good stock to buy).
- Make your BLFS purchase: Decide if you will purchase BLFS shares at the current market price or use a limit order to purchase BLFS stock at a particular price.
- Get key alerts regarding your investment in BLFS: Create a watchlist to keep track of your investment in Biolife Solutions shares.
Step 1: Figure out where to buy Biolife Solutions stock
You need a brokerage account to access the NASDAQ market and buy BLFS stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen your brokerage, you need to fill out some personal details so you are able to buy BLFS today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new trading account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've created your account on one of the best stock trading apps, you can securely and quickly fund your account:
Watch this video walkthrough to see the process of depositing funds into your investment account.
Step 4: Research Biolife Solutions stock
Once you have identified the best place to buy Biolife Solutions stock, it's critical to research their stock before you buy, so you actually wrap your head around the risk as well as the opportunity.
Overview of key BLFS info
BLFS Zen Score
WallStreetZen was built to help average investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on BLFS's stock page.
Is BLFS stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge BLFS's intrinsic value.
Using relative valuations methods:
- BLFS may be undervalued based on its P/B ratio of 2.35x, relative to Medical Instruments & Supplies industry P/B ratio of 3.51x
You can access additional valuation analysis on BLFS's stock here.
BLFS Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the BLFS balance sheet.
- There are more short-term assets than long-term liabilities on the BLFS balance sheet.
- BLFS has cash burn of 23735000. It has enough cash and short-term investments to cover this for at least one year.
- BLFS has a low debt to equity ratio of 0.22.
- Total BLFS debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
- BLFS has $51.73M in cash and short term investments. This is not enough to cover its annual cash burn of $23.74M.
- BLFS profit margin has gone up by 0.4 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy BLFS stock, according to analysts?
Out of 1 sell side analysts who give forecasts on BLFS, the consensus analyst rating on BLFS is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Biolife Solutions stock forecast page.
Metrics for Advanced BLFS Traders
BLFS Performance Metrics
Last year, BLFS revenue was $143.27M. In the past five year, BLFS's revenue has grown by 48.65% per year. This was faster than the Medical Instruments & Supplies industry average of 9.41%.
Learn more about BLFS's earnings and revenue performance here.
Latest Insiders Trades at BLFS
Over the last 12 months, executives and large shareholders at BLFS have bought more shares than they have sold.
Sarah Aebersold, Chief Human Resources Officer of BLFS, was the latest BLFS insider to sell. They sold $6,765.00 worth of BLFS stock on Apr 22, 2024.
Research more about who owns BLFS stock here.
Can I get consistent income from BLFS stock?
No, Biolife Solutions doesn't provide an income stream by paying out dividends.
What others are saying about BLFS
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your BLFS purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you require additional help investing in stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your investment in BLFS
Now that you own some BLFS stock, you'll want to stay up-to-date on your investment.
Add BLFS to a watchlist to keep tabs on your BLFS stock.
BLFS Feed
How to Buy Stock in Biolife Solutions
To reiterate, here are the 6 steps you need to take to buy Biolife Solutions stock right now:
- Figure out where to buy Biolife Solutions stock
- Create your brokerage account
- Put funds into your brokerage account
- Research Biolife Solutions stock
- Make your BLFS purchase
- Get key alerts regarding your investment in BLFS
If you require a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Biolife Solutions, click the button below.
Other Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.